Literature DB >> 25630211

Breast cancer genes: looking for BRACA's lost brother.

Borys A Cornejo-Moreno, Diego Uribe-Escamilla, Fabio Salamanca-Gómez.   

Abstract

Breast cancer, specifically mammary carcinoma, is the most common cause of death from cancer in women worldwide, with a lifetime risk of one in nine, and its prevalence is increasing. It represents around 30% of all cancer in females and approximately 40,000 deaths in the United States per year. Important advances have been made in detection and treatment, but a significant number of breast cancers are still detected late. This summary of its epidemiology and history, the molecular aspects of detection and the main implicated genes emphasizes the etiology and heterogeneity of the disease. It is still not clear whether the remaining cases of breast cancer negative to BRCA are due to mutations in another high penetrance gene or to unknown factors yet to be discovered.

Entities:  

Mesh:

Year:  2014        PMID: 25630211

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  4 in total

1.  Distinct microbiological signatures associated with triple negative breast cancer.

Authors:  Sagarika Banerjee; Zhi Wei; Fei Tan; Kristen N Peck; Natalie Shih; Michael Feldman; Timothy R Rebbeck; James C Alwine; Erle S Robertson
Journal:  Sci Rep       Date:  2015-10-15       Impact factor: 4.379

2.  Effect of bis(hydroxymethyl) alkanoate curcuminoid derivative MTH-3 on cell cycle arrest, apoptotic and autophagic pathway in triple-negative breast adenocarcinoma MDA-MB-231 cells: An in vitro study.

Authors:  Ling-Chu Chang; Min-Tsang Hsieh; Jai-Sing Yang; Chi-Cheng Lu; Fuu-Jen Tsai; Je-Wei Tsao; Yu-Jen Chiu; Sheng-Chu Kuo; Kuo-Hsiung Lee
Journal:  Int J Oncol       Date:  2017-11-14       Impact factor: 5.650

Review 3.  Understanding breast cancer - The long and winding road.

Authors:  Kiven Erique Lukong
Journal:  BBA Clin       Date:  2017-01-27

4.  Development of a risk-stratification scoring system for predicting risk of breast cancer based on non-alcoholic fatty liver disease, non-alcoholic fatty pancreas disease, and uric acid.

Authors:  Chuntian Hong; Yonghao Yan; Liyang Su; Debo Chen; Changqing Zhang
Journal:  Open Med (Wars)       Date:  2022-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.